Sicart Associates’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
JIM
KBG
Sicart Associates's PTEN Position: Q1 2021 in Review
Sicart Associates sold out of Patterson-UTI (PTEN) in Q1 2021, closing a stake of 273,395 shares — an estimated $1.44M sold.
Sicart Associates first reported a position in PTEN in Q4 2016 and held it in 17 quarters. The position peaked at $11.9M in Q2 2018. 212 funds tracked by Wall St. Rank hold PTEN as of Q1 2021.
- Sicart Associates reported no remaining Patterson-UTI position as of Q1 2021 after selling out during the quarter.
- Sicart Associates sold 273,395 Patterson-UTI shares in Q1 2021, an estimated $1.44M.
- Sicart Associates first reported a position in Patterson-UTI in Q4 2016 and held it in 17 quarters.
- Sicart Associates's Patterson-UTI position peaked at $11.9M in Q2 2018.
- 212 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2021.
Based on Sicart Associates's 13F filing for Q1 2021, filed 10 May 2021.